INNOGEN-B (02591) announced that on March 17, 2026, the company submitted an application to the China Securities Regulatory Commission for the proposed conversion of all its domestic unlisted shares into H-shares. Upon obtaining all relevant approvals and/or completing required filings—including the filing notice from the CSRC and approval from the Hong Kong Stock Exchange—and complying with all applicable laws, rules, and regulations, these domestic non-listed shares will be converted into H-shares. The company will then apply for approval to list and trade these H-shares on the Main Board of the Hong Kong Stock Exchange. According to the company's articles of association, no further shareholder meeting approval is required for the conversion and listing.
Comments